Skip to main content
 

A Cure Within - A conversation with Neil Canavan

Tuesday, December 12, 2017

Neil Canavan joins guest host Linda House to talk about his new book “A Cure Within: Scientists Unleashing the Immune System to Kill Cancer” and shed some light on the history of immunotherapy and the scientists who have persisted in order to turn what was once a scientific hypothesis into reality. Based entirely on interviews with the investigators, this book is the story of the immuno-oncology pioneers. It's a story of failure, resurrection, and success. It's a story about science, it's a story about discovery, and intuition, and cunning. It's a peek into the lives and thoughts of some of the most gifted medical scientists on the planet.

Advancing Research for Pancreatic Cancer

Wednesday, April 19, 2017

In 2016, an estimated 53,000 people were diagnosed with pancreatic cancer—making it the 12th most common cancer in the United States. Unfortunately though, only about 7.7% of patients with pancreatic cancer survive with the disease beyond five years. This difficult-to-treat disease relies on new and innovative therapies to provide hope and support to patients and families impacted by this diagnosis. In this third installment of our series on cancer clinical trials, host Kim Thiboldeaux and guest Dr. Allyson Ocean will be talking about pancreatic cancer and the need for clinical trials to discover new treatments and hope.

Frankly Speaking About Cancer: Join host Kim Thiboldeaux, President and CEO of the Cancer Support Community, for a weekly radio broadcast empowering listeners to live well with cancer. Every Tuesday, 4PM ET (1PM PT)

A Search for Answers in Unlikely Places- A conversation with Dr. James Welsh

Tuesday, May 31, 2016

Where do scientists get the ideas that lead them down a path of inquiry and discovery? Like an old fashioned private eye, this episode’s guest, Dr. James Welsh, is following clues and chasing leads that he hopes hold the answers to mysterious events he has witnessed as a doctor-- and on this episode we get to go on the ride with him. Dr. Welsh is the author of the recently released book “Sharks Get Cancer, Mole Rats Don't: How Animals Could Hold the Key to Unlocking Cancer Immunity in Humans.”

Frankly Speaking About Cancer: Join host Kim Thiboldeaux, President and CEO of the Cancer Support Community, for a weekly radio broadcast empowering listeners to live well with cancer. Every Tuesday, 4PM ET (1PM PT)

Encore: Racial Disparities in Breast Cancer Mortality

Tuesday, February 16, 2016

In this episode, hear how a person’s race could affect their chance of surviving breast cancer. As many know, a person’s experience with a breast cancer diagnosis, their treatment and their risk of dying is very different depending on the race of that patient. Dr. Steven Whitman, Director of the Sinai Health Institute and Marc Hurlbert, Executive Director of the Avon Foundation’s global breast cancer programs discuss their new study of this racial disparity across the U.S.’s 25 largest cities and the implications of their research.

Frankly Speaking About Cancer: Join host Kim Thiboldeaux, President and CEO of the Cancer Support Community, for a weekly radio broadcast empowering listeners to live well with cancer. Every Tuesday, 4PM ET (1PM PT)

Innovation Happens: The Electronic Nose

Tuesday, December 8, 2015

Over the years there have been numerous studies on dogs' ability to detect cancer and how that ability might be applied in a clinical setting. This work is particularly important for cancers for which there are currently no effective means of detection or for which the testing process is extremely invasive.

Today, in the latest installment of our series Innovation Happens, we’re going to take a look at electronic noses. Inspired by dogs’ natural smelling ability, scientists and engineers are working to develop machines that will allow doctors to quickly and effectively detect cancers.

Frankly Speaking About Cancer: Join host Kim Thiboldeaux, President and CEO of the Cancer Support Community, for a weekly radio broadcast empowering listeners to live well with cancer. Every Tuesday, 4PM ET (1PM PT)

Encore Presentation: Innovation Happens Part 3- A Conversation with Jack Andraka

Tuesday, June 23, 2015

In this third installment of the Innovation Happens series, host Kim Thiboldeaux takes a look at an unexpected route to innovation by talking to teen inventor Jack Andraka. Jack was just fifteen years old when he invented an inexpensive early detection test for pancreatic, ovarian and lung cancers.

His groundbreaking work has earned him international recognition, most notably the 2012 Intel ISEF Gordon Moore Award and the 2012 Smithsonian American Ingenuity Youth Award. Jack was First Lady Michelle Obama’s personal guest at the 2013 State of the Union Address. Jack is now a seventeen year old high school senior and hasn’t slowed down a bit.

Frankly Speaking About Cancer: Join host Kim Thiboldeaux, President and CEO of the Cancer Support Community, for a weekly radio broadcast empowering listeners to live well with cancer. Every Tuesday, 4PM ET (1PM PT)

Innovation Happens (Part 3) - A Conversation with Jack Andraka

Tuesday, April 7, 2015

In this third installment of the Innovation Happens series, host Kim Thiboldeaux takes a look at an unexpected route to innovation by talking to teen inventor Jack Andraka. Jack was just fifteen years old when he invented an inexpensive early detection test for pancreatic, ovarian and lung cancers.

His groundbreaking work has earned him international recognition, most notably the 2012 Intel ISEF Gordon Moore Award and the 2012 Smithsonian American Ingenuity Youth Award. Jack was First Lady Michelle Obama’s personal guest at the 2013 State of the Union Address. Jack is now a seventeen year old high school senior and hasn’t slowed down a bit.

Frankly Speaking About Cancer: Join host Kim Thiboldeaux, President and CEO of the Cancer Support Community, for a weekly radio broadcast empowering listeners to live well with cancer. Every Tuesday, 4PM ET (1PM PT)

Encore Presentation: Confronting Research Funding for Hard-to-Beat Cancers

Tuesday, November 4, 2014

Lung cancer is the leading cause of cancer death in the United States, and pancreatic cancer has one of the lowest 5-year survival rates of all cancers. Despite these facts and figures, lung cancer, pancreatic cancer and other hard-to-beat cancers of the liver, esophagus, stomach and ovary have historically been given the lowest amount of government research funding. The Recalcitrant Cancer Research Act is working to change that.

Kim Thiboldeaux is joined by Megan Gordon Don, Vice President of Government Affairs & Advocacy at the Pancreatic Cancer Action Network, and Dr. Jim Dougherty, medical and scientific advisor for the Lung Cancer Research Foundation, to talk more about what this law means and why it was so necessary in the first place.

Frankly Speaking About Cancer: Join host Kim Thiboldeaux, President and CEO of the Cancer Support Community, for a weekly radio broadcast empowering listeners to live well with cancer. Every Tuesday, 4PM ET (1PM PT)

Pages